Rieder Wendy E

Avg. Two Year Performance

No purchase track record
3% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(16%)(4%)(10%)17%3%
Sale Success Rate0 of 31 of 32 of 33 of 31 of 3

Synta Pharmaceuticals Corp.

Drugs » Diagnostic Substances

Former SVP, Gen. Counsel:

Holdings: 17.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--